Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00626821 · ClinicalTrials.gov registry record · Phase 4
Coloplast DialogueStudy
A Phase 4 study, sponsored by Coloplast A/S.
- Completed
- Registry status
- Phase 4
- Development phase
- 3,017
- Enrollment target
NCT00626821: Completed Phase 4 study, sponsored by Coloplast A/S.
NCT00626821 is a Phase 4 study that has completed, run by Coloplast A/S. The registered enrollment target is 3,017 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (482% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00626821, a Phase 4 study, has completed, sponsored by Coloplast A/S.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 3,017 participants
- Enrollment target
Study Summary
The main purpose of the study is to document real life experience on SenSura with focus on skin condition and quality of life.
Primary Outcome
The mean change in quality of life (Stoma-QoL value) from visit 1 to visit 2. An increase in Stoma-QoL is an improvement, a decrease in Stoma-QoL is a worsening.
Interventions
- DEVICE SenSura
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,017 participants |
| Start Date | 2008-02 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
What the finished NCT00626821 record still lists
NCT00626821 is an interventional study that assigns participants to a tested intervention. Its 3,017 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (482% higher).
The record links to 0 conditions, and to 1 intervention - of which SenSura is the first listed.
NCT00626821 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00626821 about?
NCT00626821 is a clinical study titled "Coloplast DialogueStudy". The main purpose of the study is to document real life experience on SenSura with focus on skin condition and quality of life.
What is the current status of trial NCT00626821?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 3,017 participants. The study started on 2008-02. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00626821?
The interventions under investigation include: SenSura (DEVICE).
Who is sponsoring clinical trial NCT00626821?
This trial is sponsored by Coloplast A/S, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00626821's enrollment target sits among peer trials
3,017 25th of 2000 higher than 1,976 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia